***********************************
Brakke Consulting’s
Animal Health News & Notes for July 17, 2015
Copyright © Brakke Consulting, Inc.
Editor: Lynn Fondon DVM MBA
************************************
IN THE NEWS:
Brakke Consulting news
Changing Pet Ownership study
Transaction assistance
earnings news
Virbac
other news
Abbott
Aptimmune Biologics
Assisi Animal Health
Bio Health Solutions
Elanco
Henry Schein
Maravet
Merial
Nipro Medical Corporation
Oasmia Pharmaceutical
PetCure Oncology
Thermo Fisher Scientific
Vets Plus
Zoetis (veterinary fluids)
Zoetis (Paccal Vet)
***********************************
BRAKKE CONSULTING, INC.
CHANGING PET OWNERSHIP STUDY
PRE-ORDER DISCOUNT ENDS AUGUST 7, 2015
Brakke Consulting, Inc., and Trone Brand Energy have launched the Changing Pet Ownership Study, which will explore the evolutionary change in pet owner attitudes, lifestyle and purchase behavior and the implications to future pet ownership. The study will address how pet owners and the pet population are likely to change, how to best communicate with these groups in the future, as well as where pet owners will obtain information and how they will make their pet product purchase decisions.
The study is available from Brakke Consulting for $28,000. Companies that subscribe by August 7, 2015 and pre-pay 50% receive an early-order discounted price of $25,000. The full report will be available at the end of the first quarter of 2016.
For more information, or to participate in the study, contact David Goodnight at 830-285-1259 or DGoodnight@BrakkeConsulting.com .
www.BrakkeConsulting.com
***********************************
COMPANY EARNINGS RELEASES
> Virbac S.A. reported results for the second quarter of 2015. Consolidated revenue was EUR 221 million ($245 million), an increase of 19% compared to the same period of last year. At constant exchange rates, growth was 9%. Performance was driven on one hand by the addition of the Sentinel brand acquired earlier this year, and on the other hand by 7% organic growth outside of the US, which was impacted by the interruption of operations in the St. Louis, Missouri manufacturing facility. Organic growth during the quarter was 2%. (company website)
************************************
COMPANY NEWS RELEASES
> Zoetis Inc. announced that it has extended supply agreements to continue providing its US customers with the veterinary-labeled fluids essential for their patients. The product line was acquired via Zoetis’ acquisition of Abbott Animal Health in February 2015. According to Zoetis, these products are the only veterinary-labeled fluids currently on the market. (company press release)
> Oasmia Pharmaceutical announced that it has established a sales presence in the US for Paccal Vet-CA1 (paclitaxel), a cancer drug that was conditionally approved by the FDA in 2014 and was formerly distributed by Zoetis via its acquisition of Abbott Animal Health. In addition, Oasmia took back the rights to Doxophos Vet, a formulation of the chemo drug doxorubicin. Oasmia has also filed an F-1 to the SEC to offer $23 million worth of shares on the Nasdaq exchange. (FierceAnimalHealth)
> Merial announced the launch of OraVet Dental Hygiene Chews for dogs. The chews, which are administered daily, use exclusive new dual action technology – including an innovative compound (delmopinol) originally developed for human dentistry – to significantly reduce the formation of plaque, calculus and halitosis at their source. (company press release)
> Vets Plus, Inc., announced the launch of Probios Pro-Pill Pods, a convenient, simple way to give medication to dogs. These unique pods can be shaped around a pill to mask unsavory flavors and odor, making the process of giving a pill hassle-free. Plus, they contain probiotics so dogs get the added benefit of good bacteria for digestion and appetite. (company press release)
> Assisi Animal Health launched the Assisi Loop 2.0, a non-pharmaceutical anti-inflammatory device (NPAID) that uses patented targeted pulsed electromagnetic field (tPEMF) technology that has been demonstrated through laboratory testing to have a proven effect on the known biochemical and cellular mechanisms of action related to inflammation. (PRNewswire)
> The FDA has filed a consent decree against Bio Health Solutions and its owner, three years after warning the company to stop marketing its unapproved compound, RenAvast, for veterinary use. The company had been marketing RenAvast to treat a variety of kidney conditions in cats and dogs, including chronic renal failure. The action prevents the company from marketing RenAvast or any other unapproved drug. (FDA)
> Nipro Medical Corporation announced the launch of Nipro VSmart products dedicated to the veterinary market. Nipro is a leading manufacturer of medical devices including syringes, needles, IV catheters and winged infusion sets. (company press release)
> Aptimmune Biologics announced it has raised $2.75 million of funding following a series A round. The firm is developing mucosal vaccines, specifically for porcine reproductive and respiratory syndrome (PRRS) virus and swine influenza. Aptimmune’s lead candidate for PRRS is about to enter US registration trials. (Animal Pharm)
> PetCure Oncology, created by the founders of Accelitech, announced the launch of a national network of veterinary stereotactic radiosurgery centers. The first location opened in May in Gilbert, Arizona. Many more locations across the country are in various stages of development. (Business Wire)
> CANADA Elanco Animal Health and Concordia University announced a collaboration to develop new enzyme combinations for Canadian pork and poultry producers. The goal of the project is to create commercial enzyme products for pork and poultry feed that significantly improve feed conversion, thus improving producer profit margins. (WattAgNet)
> ROMANIA Henry Schein announced that it has made a 50% ownership investment in Maravet, a leading animal health distributor in Romania. Maravet is a privately-held company with annual sales of approximately $23 million. The company was founded in 1998 by the Korponay family, which retains a 50% ownership position in Maravet. Financial terms of the transaction were not disclosed. (Streetinsider.com)
> EU Thermo Fisher Scientific announced the launch of PrioCHECK Trichinella AAD, a cleaner, safer way to test swine carcasses for Trichinella at meat inspection. The alternative artificial digestion (AAD) method has been validated and approved by the EU. (company press release)
***********************************
2015 KC Animal Health Corridor Homecoming Dinner
Monday, August 31, 2015
Kansas City Convention Center
Connect with nearly 900 animal health industry professionals and join the Corridor in honoring this year’s Iron Paw Award recipient, Dr. Ralph Richardson. Hear from Dayton Moore, General Manager of the Kansas City Royals, as he shares his strategy for building a winning team and a culture of success.
The event will be held on Monday, August 31 from 5 – 9 p.m. at the Kansas City Convention Center Grand Ballroom.
Visit http://www.eventbrite.com/e/kc-animal-health-corridor-homecoming-dinner-2015-tickets-16992385683 for registration.
Visit http://kcanimalhealth.thinkkc.com/events/homecoming for full event details.
***********************************
ANIMAL HEALTH NEWS
> US – SWINE HEALTH A new Swine Health Information Center has been established in Iowa in space leased from American Association of Swine Veterinarians (AASV). The National Pork Board (NPB) has provided $15 million in Pork Checkoff funding over five years. The center is an independent organization that will work closely with veterinarians, pork producers, swine genetics companies, animal-health product providers and public and private organizations to develop an international swine health information network to identify and prioritize high-risk pathogens worldwide. (Feedstuffs)
> CANADA – DIAGNOSTIC LAB The Canadian provinces of Newfoundland and Labrador have opened a C$3.9 million ($3.1 million) facility to help improve its fight against animal diseases. The Foreign Animal Disease Laboratory Complex features a molecular diagnostics laboratory, rabies laboratory, necropsy room and incinerator. (Animal Pharm)
> US – FOOD LABELING The US House Agriculture Committee voted favorably to advance the bipartisan Safe and Accurate Food Labeling Act to the House floor, creating a framework for the voluntary labeling of GMO-free foods. As state legislatures and ballot initiatives have developed labeling standards, Congressional leaders have said it’s needed to step in to create a national standard and take out the confusion that’s created from a piecemeal approach. It also requires FDA to proposed definitions of “natural” food within 18 months and these definitions would cover wording such as what can be classified as “100% natural” and “all natural” and “made with natural ingredients.” (Feedstuffs)
************************************
BRAKKE CONSULTING, INC.
TRANSACTION ASSISTANCE
Let Brakke Consulting provide assistance for all your transactions.
Brakke Consulting has been the finder of record, agent of record or consultant for a number of successfully completed projects. We assist with valuations and provide due diligence on confidential transactions as well as offering executive counsel on a number of potential transactions.
Brakke Consulting has the experience, insight, ability and contacts to provide clients with the highest quality services in the animal health, pet, veterinary and specialty chemicals markets. Please contact any of our offices for a confidential consultation.
www.BrakkeConsulting.com
***********************************
AVMA ANNUAL CONVENTION
BOSTON
JULY 10 – 14, 2015
The AVMA held its annual conference in Boston, Massachusetts this week. The conference included over 8,700 attendees, including nearly 4,000 veterinarians and 1,500 exhibitors. The conference offered close to 1,000 continuing education sessions for veterinarians and staff members, including interactive laboratories and workshops and a full day of lectures on the Ebola virus.
************************************
BRAKKE CONSULTING VIEWPOINT
Congratulations to the American Veterinary Medical Association on an outstanding, meaty annual convention this week in Boston. And congratulations to Dr. Joe Kinnarney, new president of AVMA who challenged the AVMA and its members to return to the profession’s “entrepreneurial roots.”
Several new products, referenced earlier in this newsletter, were announced at this year’s event. A new corporate face at the convention was petfood company Blue Buffalo, which won the award for the best booth by a new exhibitor. Although it hasn’t made an official announcement yet, Blue Buffalo was showcasing a new line of therapeutic diets that it will begin selling later in the year, in competition with Hill’s, Royal Canin and Nestle Purina.
Thank you for the many favorable comments we heard at the convention about the new Veterinary Pharmaceutical Shift Study recently published by Brakke Consulting and Trone Brand Energy. This newsletter carries the announcement of a new study from this partnership, Changing Pet Ownership. It will document the increasing importance of millennials, Hispanics and other demographic groups, and how their purchase behavior differs from previous generations. You will find it to be a valuable resource for your marketing program.
John Volk
Senior Consultant
**********************************
This electronic newsletter is the sole property of Brakke Consulting, Inc.
Any use of the contents herein should be approved by and appropriately attributed to Brakke Consulting, Inc.
For more information about Brakke Consulting’s services and syndicated studies, visit our website at www.brakkeconsulting.com.
Brakke Consulting, Inc.
12005 Ford Rd., Suite 530
Dallas, TX 75234 USA
English (United States) 
Portuguese